| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |